August 6, 2021

New Enzyme Replacement Therapy Approved for Pompe Disease

Read More
August 6, 2021

Two Lots of Atovaquone Oral Suspension Recalled

Read More
August 2, 2021

Saphnelo Approved as First-in-Class Treatment for Lupus

Read More
August 1, 2021

Brand Medications with Generic Alternatives Anticipated to be Approved in September

Read More
July 30, 2021

REGEN-COV Authorized for Post-Exposure Prevention of COVID-19

Read More
July 29, 2021

Nucala Receives New Nasal Polyps Indication

Read More
July 29, 2021

Changes Made to Risk Evaluation and Mitigation Strategy for Drug Approved to Treat Schizophrenia

Read More
July 28, 2021

Keytruda Receives Two New Indications, Bringing Total Number to 30

Read More
July 28, 2021

FDA Makes Semglee the First Interchangeable Biosimilar

Read More
July 28, 2021

Olumiant Authorized for Use Alone to Treat COVID-19 in Hospitalized Patients

Read More
July 28, 2021

Pepaxto Associated with Increased Risk of Death in a Clinical Trial

Read More
July 27, 2021

First Fixed-Dose Combination of Tretinoin and Benzoyl Peroxide Receives FDA Approval to Treat Acne

Read More